Finerenone increases the likelihood of improved KDIGO risk category in patients with CKD and type 2 diabetes: An analysis from FIDELITY.

Weingold R, Filippatos G, Anker SD, Wanner C, Shafi T, Tangri N, Pitt B, Brinker M, Scott C, Roberts L, Rossing P, Inzucchi SE, FIDELIO-DKD and FIGARO-DKD Investigators

Open source

DOI: 10.1016/j.jdiacomp.2026.109274
Published: 2026 Apr
Container: Journal of diabetes and its complications
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.jdiacomp.2026.109274,
  title = {Finerenone increases the likelihood of improved KDIGO risk category in patients with CKD and type 2 diabetes: An analysis from FIDELITY.},
  author = {Weingold R and Filippatos G and Anker SD and Wanner C and Shafi T and Tangri N and Pitt B and Brinker M and Scott C and Roberts L and Rossing P and Inzucchi SE and FIDELIO-DKD and FIGARO-DKD Investigators},
  year = {2026},
  journal = {Journal of diabetes and its complications},
  doi = {10.1016/j.jdiacomp.2026.109274},
  url = {https://doi.org/10.1016/j.jdiacomp.2026.109274}
}

RIS

TY  - JOUR
TI  - Finerenone increases the likelihood of improved KDIGO risk category in patients with CKD and type 2 diabetes: An analysis from FIDELITY.
AU  - Weingold R
AU  - Filippatos G
AU  - Anker SD
AU  - Wanner C
AU  - Shafi T
AU  - Tangri N
AU  - Pitt B
AU  - Brinker M
AU  - Scott C
AU  - Roberts L
AU  - Rossing P
AU  - Inzucchi SE
AU  - FIDELIO-DKD and FIGARO-DKD Investigators
PY  - 2026
JO  - Journal of diabetes and its complications
DO  - 10.1016/j.jdiacomp.2026.109274
UR  - https://doi.org/10.1016/j.jdiacomp.2026.109274
ER  -

APA

R, W., G, F., SD, A., C, W., T, S., N, T., B, P., M, B., C, S., L, R., P, R., SE, I., & Investigators, F. A. F. (2026). Finerenone increases the likelihood of improved KDIGO risk category in patients with CKD and type 2 diabetes: An analysis from FIDELITY.. Journal of diabetes and its complications. https://doi.org/10.1016/j.jdiacomp.2026.109274

Source records

pubmed · retrieved 2026-09-26T22:58:44.513Z
europe-pmc · retrieved 2026-09-26T22:58:44.532Z